Release time：Jul 27, 2022
On July 25, the Science and Technology Commission of Shanghai Municipality published a list of 2021 New Shanghai Technology Innovation Center. After the review and discussion of experts, Mabwell (688062.SH), by virtue of its outstanding capabilities in the fields of technological innovation and R&D, commercial manufacturing and quality management, serves as a supporting enterprise of the Shanghai Technology Innovation Center for Antibody Drug Discovery and Industrialization.
Key Research Directions of Shanghai Technology Innovation Center for Antibody Drug Discovery and Industrialization
Focusing on a large number of unmet clinical needs in the field of innovative antibody drugs, the Shanghai Technology Innovation Center for Antibody Drug Discovery and Industrialization is expected to make critical and common technological breakthrough on innovative antibody drugs based on the demands of long-term systematic construction and improvement of antibody drug innovation and R&D capabilities in China, break the international containment on technologies and materials in the antibody drug industrialization, realize the establishment of international advanced antibody drug innovation platforms and systems, empower independent innovation, development and manufacture of new antibody drugs with strong accessibilities, and fill international and domestic gaps.
The construction of Shanghai Technology Innovation Center closely fits the needs of technological innovation in Shanghai's key industries, has clear objectives and directions, and possesses a good foundation of research and team building, which are of great significance for enhancing the technological innovative capability of enterprises, leading the innovative development of key industries and fostering national-level innovation bases. Seven key enterprises included in the list of New Shanghai Technology Innovation Center involve different innovative directions in the field of bio-pharmaceuticals.
Fields:
- Integrated circuit
- Artificial intelligence
- Advanced manufacturing
- Bio-pharmaceuticals
- New energy and new materials
